Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL2018659

CCNCC(=O)NCCO.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
CNR1 P21554 5/20 0.36
MEN1 O00255 2/20 0.36
BLM P54132 2/20 0.36
KMT2A Q03164 2/20 0.36
TRPV1 Q8NER1 2/20 0.36
TRPM8 Q7Z2W7 1/20 0.36
FAAH O00519 1/20 0.36
KCNK3 O14649 1/20 0.36
CNR2 P34972 1/20 0.36
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
ALOX12 P18054 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2019891 0.87 CNR1 (0.42) ALDH1A1CNR1MEN1BLMKMT2A
Trifluoroacetic Acid SCHEMBL28340710 0.85 MCL1 (0.41) ALDH1A1KMT2AFAAH
Trifluoroacetic Acid SCHEMBL31245497 0.82 DNM1 (0.44) ALDH1A1MAPTLMNA
SCHEMBL2019288 0.76 MEN1 (0.46) ALDH1A1CNR1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL3651032 0.75 FFAR3 (0.35) ALDH1A1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL28399119 0.75 TP53 (0.40) MEN1KMT2AFAAH
Trifluoroacetic Acid SCHEMBL2242176 0.74 TP53 (0.44) ALDH1A1MEN1KMT2AFAAH
Trifluoroacetic Acid SCHEMBL28343191 0.74 ALDH1A1 (0.39) ALDH1A1CNR1MEN1KMT2AMAPT
SCHEMBL2016710 0.74 KMT2A (0.38) ALDH1A1MEN1KMT2AGAA
SCHEMBL2018660 0.73 ALDH1A1 (0.33) ALDH1A1TDP1TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110160180-A1 Cannabinoid Receptor Ligands ASTRAZENECA AB (SE) 2011-06-30 US disclosed
EP-2190838-A1 CANNABINOID RECEPTOR LIGANDS AstraZeneca AB (SE) 2010-06-02 EP disclosed
US-20090062251-A1 Novel Compounds 002 ASTRAZENECA AB (SE) 2009-03-05 US disclosed
WO-2009024819-A1 CANNABINOID RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062251-A1 Novel Compounds 002 OPRL1, OPRK1, OPRM1 ALDH1A1 517/4885CNR1 17/4885MEN1 3055/4885
US-20110160180-A1 Cannabinoid Receptor Ligands CNR1, CNR2, OPRL1 ALDH1A1 2240/4885CNR1 1/4885MEN1 3215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.